Nuha A El Sayed
Dr Nuha A El Sayed, MD, PhD is an expert in Endocrinology at Brigham and Women's Hospital (United States). As of October 2026, ScienceLeadR ranks Nuha A El Sayed in the top 1% of experts worldwide for Diabetes Mellitus and Glucose Metabolism Disorders. Nuha A El Sayed has authored 134 publications, the most recent in 2026. SLR score: 493 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Public Health - Internal Medicine - Nutrition
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2020 - 2026
Number : 134
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| RAAS Inhibitors for the Primary Prevention of CKD in Type 1 and Type 2 Diabetes: A Systematic Review and Meta-analysis. PMID 42935605 — diabetes mellitus, hypertension, albuminuria, primary prevention, diabetes mellitus, type 1, diabetes mellitus, type 2 | Diabetes Obes Cardiometab CARE | 2026 | 0 |
| Employment and Diabetes: A Statement of the American Diabetes Association. PMID 42935834 — diabetes mellitus, employment, work | Diabetes Obes Cardiometab CARE | 2026 | 2 |
| Enhancing Physician Clinical Competency: A Cluster Randomized Trial of a Multimodal Online Educational Program in a Multinational Diabetes Workforce. PMID 42936084 — diabetes mellitus, physicians, learning, education, clinical competence, workforce | Diabetes Obes Cardiometab CARE | 2026 | 0 |
| Estimating the Health, Economic, and Social Benefits of Obesity Treatment Using Microsimulation Modeling. PMID 42936006 — quality of life, mortality, obesity, therapeutics | Diabetes Obes Cardiometab CARE | 2026 | 2 |
| SGLT2 Inhibitors for the Primary Prevention of CKD in Type 2 Diabetes: A Systematic Review and Meta-analysis. PMID 42935914 — diabetes mellitus, sodium-glucose transporter 2 inhibitors, albuminuria, primary prevention, diabetes mellitus, type 2 | Diabetes Obes Cardiometab CARE | 2026 | 0 |
LeadR Networks
Main global connection map